Eric M. Ruderman, MD
Professor of Medicine
Associate Chief, Clinical Affairs
Division of Rheumatology
Feinberg School of Medicine
Joseph F. Merola, MD, MMSc
Associate Professor, Harvard Medical School
Director, Clinical Unit for Research Innovation and Trials (CUReIT), Dermatology
Director, Center for Skin and Related Musculoskeletal Diseases
Deptartment of Dermatology and Department of Medicine, Division of Rheumatology
Associate Program Director, Combined Medicine-Dermatology Residency Program
Brigham and Women's Hospital
0.5 AMA PRA Category 1 Credit™
The underdiagnosis and undertreatment of psoriatic arthritis represents a significant healthcare gap that increases the potential for severe disease burden, including decreased physical function and quality of life. This interactive patient simulation will examine screening, diagnosis and evidence-based treatment options.
Rheumatologists, rheumatology NPs and PAs, dermatologists, dermatology NPs and PAs, and other clinicians who encounter patients with psoriasis and PsA, including general practice/internal medicine clinicians.
Upon completion of this educational activity, the participant should be able to:
- Diagnose psoriatic arthritis using clinical examination, questionnaires, and laboratory and imaging studies.
- Develop a management plan for newly diagnosed patients with psoriatic arthritis based on disease severity.
Joseph F. Merola, MD, MMSc, discloses the following conflicts of interest.
Consultant and/or investigator: AbbVie, Aclaris, Almirall, Biogen, Celgene, Dermavant, GSK, Incyte, Janssen, Leo Pharma, Lilly, Merck, Novartis, Pfizer, Samumed, Sanofi Regeneron, Sun Pharma, UCB
Eric M. Ruderman, MD, discloses the following conflicts of interest.
Consultant: AbbVie, Amgen, GSK, Janssen, Lilly, Novartis, Pfizer
Research support: Coronna
Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.
Bruce C. Gebhardt, MD, CME Reviewer-Compliance, University of Cincinnati, has no conflicts of interest to disclose.
Heather Muskopf, Program Manager, Continuing Medical Education, University of Cincinnati, has no conflicts of interest to disclose.
Lillian McVey, Writer/Editor, MCM Education, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
The University of Cincinnati requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity was developed through the joint providership of the University of Cincinnati and MCM Education.
Release date: February 13, 2019
Last review date: February 13, 2019
Expiration date: February 13, 2020
Please contact the University of Cincinnati Continuing Medical Education Department at email@example.com or call 513-558-7277.
For any technical issues or issues with your CME Certificate, please contact firstname.lastname@example.org.
Commercial Support Statements
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
- Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
- Accessing Activity:
* Click "Start Program"
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your credit/participation in this activity
There is no charge for CME credit.
©2019 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Cincinnati, or Novartis Pharmaceuticals Corporation. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.